Optimization of Biotinylation Protocol for Studies of Red Blood Cell Survival and Function After Transfusion
Early Phase 1
Completed
- Conditions
- Measuring Red Blood Cell Survival After Transfusion
- Interventions
- Drug: BioRBC
- First Posted Date
- 2025-01-22
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Vitalant Research Institute
- Target Recruit Count
- 12
- Registration Number
- NCT06788080
- Locations
- 🇺🇸
Anschutz Medical Center, Aurora, Colorado, United States
🇺🇸Vitalant Research Institute, Denver, Colorado, United States
Improving Blood Safety and HIV Testing in Brazil
Not Applicable
Completed
- Conditions
- HIVHepatitis BHepatitis CHerpes Simplex 2Chagas Disease
- Interventions
- Behavioral: HIV Counseling and TestingBehavioral: Blood Donation
- First Posted Date
- 2012-09-10
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Vitalant Research Institute
- Target Recruit Count
- 11900
- Registration Number
- NCT01681420
- Locations
- 🇧🇷
Fundação Pró-sangue Hemocentro de São Paulo, Sao Paulo, Brazil
Detailed Evaluation of Microchimerism
Withdrawn
- Conditions
- ChimerismBlood TransfusionWounds and InjuriesHematopoiesis
- First Posted Date
- 2010-03-26
- Last Posted Date
- 2013-04-12
- Lead Sponsor
- Vitalant Research Institute
- Registration Number
- NCT01094197
- Locations
- 🇺🇸
University of California, Davis, Medical Center, Sacramento, California, United States
Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury
Completed
- Conditions
- Wounds and InjuriesChimerismBlood Transfusion
- First Posted Date
- 2006-11-16
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- Vitalant Research Institute
- Target Recruit Count
- 451
- Registration Number
- NCT00400192
- Locations
- 🇺🇸
University of California, Davis, Medical Center, Sacramento, California, United States
© Copyright 2025. All Rights Reserved by MedPath